{"url_path":"/sec/ctrvp/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1583771/0001493152-26-023136-index.html","accession_number":"0001493152-26-023136","cik":"0001583771","ticker":"HEPA","issuer_name":"Hepion Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1583771/0001493152-26-023136-index.html","primary_entity_key":"0001583771","primary_entity_name":"Hepion Pharmaceuticals, Inc."},"word_count":42,"has_tables":true,"body_markdown":"**ITEM\n5. Other Information**\n\n \n\nDuring\nthe three months ended March 31, 2026, no director or officer adopted or terminated any Rule 10b5-1 trading arrangement, and/or any non-Rule\n10b5-1 trading arrangement (as such terms are defined pursuant to Item 408(a) of Regulation S-K)."}